A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)
Clinical trial NCT06343948 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06343948
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-24
- Primary completion
- 2026-08-01
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.